Should persons with acute myeloid leukemia (AML) in 1st histological complete remission who are measurable residual disease (MRD) test positive receive an allotransplant?

Overview of attention for article published in Leukemia, March 2020

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (51st percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 5 X users

Readers on

mendeley: 28 Mendeley

Summary X

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 9,532 followers.

To transplant or not to transplant? Great discussion on MRD in AML #acutemyeloidleukaemia @LeukemiaJnl https://t.co/aWtQvqoziR

11 Sep 2020

Reply Repost Favourite

Venditti, A., Peter Gale, R., Buccisano, F. et al. Should persons with acute myeloid leukemia (AML) in 1st histological complete remission who are measurable residual disease (MRD) test positive receive an allotransplant?. Leukemia 34, 963–965 (2020). http

16 Apr 2020

Reply Repost Favourite

https://t.co/bnnZCN1OxH Should persons with acute myeloid leukemia (AML) in 1st histological complete remission who are measurable residual disease (MRD) test positive receive an allotransplant?

11 Mar 2020

Reply Repost Favourite

RT @GarbineLizeaga: Should persons with acute myeloid leukemia (AML) in 1st histological complete remission who are measurable residual dis…

06 Mar 2020

Reply Repost Favourite

Should persons with acute myeloid leukemia (AML) in 1st histological complete remission who are measurable residual disease (MRD) test positive receive an allotransplant? https://t.co/PD5vs4CT9E

06 Mar 2020

Reply Repost Favourite